Grifò G, Lo Presti R, Montana M, Canino B, Caimi G
Insegnamento di Semeiotica e Metodologia Medica, Università, Palermo.
Recenti Prog Med. 1995 Nov;86(11):431-6.
In 4 groups of subjects with different clinical conditions: essential hypertension, diabetes mellitus without and with macrovascular complications, vascular atherosclerotic disease (VAD), we evaluated the plasma, erythrocyte and platelet magnesium content, the correlations between them and the relationships among all these parameters and metabolic and haemodynamic determinants. From the obtained data, it is evident that platelet magnesium content is decreased in hypertensives and in type 2 diabetics with macrovascular complications, and in subjects with VAD, while the red cell magnesium content in VAD subjects and in type 2 diabetics with macrovascular complications is increased; in type 1 diabetics we observed a decrease of the plasma magnesium level. The relationships between the plasma and cellular magnesium content, in the different clinical conditions, seem interesting.
在4组患有不同临床病症的受试者中：原发性高血压、无大血管并发症和有大血管并发症的糖尿病、血管动脉粥样硬化疾病（VAD），我们评估了血浆、红细胞和血小板中的镁含量、它们之间的相关性以及所有这些参数与代谢和血流动力学决定因素之间的关系。从获得的数据来看，很明显，高血压患者、有大血管并发症的2型糖尿病患者以及VAD患者的血小板镁含量降低，而VAD患者和有大血管并发症的2型糖尿病患者的红细胞镁含量增加；在1型糖尿病患者中，我们观察到血浆镁水平降低。在不同临床病症中，血浆和细胞镁含量之间的关系似乎很有趣。
